Highlights
The RESECT trial represents the largest global effort to date to standardize and improve the quality of transurethral resection of bladder tumour (TURBT) through implementation science. Key highlights include:
- Audit, feedback, and education significantly improved the documentation of tumour features and resection completeness.
- The intervention did not yield statistically significant improvements in technical surgical performance, specifically detrusor muscle sampling.
- Adherence to guidelines regarding single-instillation chemotherapy (SI) remained unchanged despite the intervention.
- Early recurrence rates were not reduced by the intervention, highlighting a persistent gap between administrative documentation and clinical efficacy.
